Mirae Asset Global Etfs Holdings Ltd. Igm Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 6,508 shares of IGMS stock, worth $108,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,508Holding current value
$108,358% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
87Shares Held
21.4MCall Options Held
39.5KPut Options Held
16.5K-
Baker Bros. Advisors LP New York, NY4.09MShares$68.1 Million0.37% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.08MShares$67.9 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.33MShares$55.5 Million1.45% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$51.2 Million1.38% of portfolio
-
Goldman Sachs Group Inc New York, NY1.33MShares$22.2 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $482M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...